Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT).

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Allogeneic bone marrow transplantation (BMT) cures diseases via stem cell support, graft-versus-tumor (GVT) effect, gene replacement, and immunoablation.
• Conventional conditioning BMT (CC-BMT) involves high-intensity conditioning, prolonged hospitalization, and 10-50% treatment-related mortality (TRM).
• CC-BMT is limited by organ toxicity and complications from profound neutropenia.

Purpose of the Study:

• To review the basic concepts and procedures of reduced-intensity conditioning BMT (RC-BMT).
• To summarize preliminary results of RC-BMT across various transplant centers.
• To highlight RC-BMT as a potentially curative and more accessible alternative to CC-BMT.

Main Methods:

• Review of preclinical and clinical advancements leading to RC-BMT procedures.
• Analysis of curative mechanisms activated by RC-BMT (GVT, gene replacement, immunoablation).
• Summary of outcomes from different centers performing RC-BMT.

Main Results:

• RC-BMT utilizes reduced conditioning, avoiding severe organ toxicity and neutropenia complications.
• RC-BMT activates key curative mechanisms, proving sufficient for certain diseases.
• RC-BMT expands eligibility to older patients and those unsuitable for CC-BMT, with potential for outpatient settings and cost reduction.

Conclusions:

• RC-BMT represents a significant advancement in allogeneic bone marrow transplantation.
• This approach offers a less toxic and more accessible treatment option for various malignant, non-malignant, and autoimmune diseases.
• Further research and broader implementation of RC-BMT are warranted to improve patient outcomes and transplant availability.